Dyne Therapeutics
VP, DM1 Commercial Asset Lead
Waltham, MA · Vp
Stay score
odds of building a lasting career here
Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.
Lottery odds assume a STEM candidate.
Personalize to your clock →Employer immigration record
from this employer's Department of Labor filings
Files H-1B transfers
Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.
Community outcomes
No reports yet — be the first to help the next applicant.
About the role
- Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
- The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.
- Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Responsibilities
- Lead global launch planning and readiness across key markets, starting with the U.S.
- Serve as a key member of the Program Team and lead the DM1 Commercial Sub-Team
- Facilitate cross-functional decision-making and drive timely outcomes
- Build strong partnerships across functions and maintain clear communication with leadership
- Build a credible and visible presence within the DM1 community, including KOLs, patient advocacy groups, and care teams
- Maintain awareness of competitive landscape and evolving market dynamics
Requirements
- Minimum of 20 years of experience in the biopharmaceutical industry
- 15+ years of commercialization and cross-functional leadership experience
- Proven track record of delivering on business objectives in fast-paced, high-stakes environments
- Proven ability to steer assets from late-stage development through approval and launch
- Ability to synthesize complex data to guide strategy
- Proven ability to inspire and mobilize high-performing teams
- Strong sense of urgency and ability to prioritize effectively
Nice to have
- advanced degree strongly preferred
- Rare disease experience strongly preferred
- neuromuscular experience highly advantageous
Compensation
- $272,000 - $340,000 USD
Benefits
- Partner with cross-functional teams (medical, regulatory, supply, marketing, digital, data) to prepare for launch execution
- Collaborate with affiliate teams and external partners to support reimbursement and access readiness
- Drive continuous improvement and learning across markets
Company info
- We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
This listing is sourced directly from Dyne Therapeutics's careers page and normalized into a canonical job model.